Sexually Transmitted Diseases

Subterms

    Latest story

    125 Shares149 Views

    How Older Daters are Coping With the Surge in S.T.I.s

    by

    Older daters are not getting adequate screening and protection from S.T.I.s. Here’s how to be a safer sexually active senior.Since her marriage of more than 20 years ended in divorce, Amy, a 62-year-old Texan, has had a couple of committed relationships and a handful of sexual partners.Amy is currently seeing a man she described as a “friend with benefits,” but it’s nothing she takes too seriously. What she does take seriously is talking to him — and every partner — about safe sex practices amid rising rates of sexually transmitted infections in seniors.“I’m very aware of it,” said Amy, who asked to use only her middle name to protect her privacy. “I require proof of negative testing before I become intimate with anyone.” She also insists on using a condom.Between 2012 and 2022, rates of syphilis, gonorrhea and chlamydia more than doubled among those 55 and older, according to data from the Centers for Disease Control and Prevention. Research suggests many older people are unaware of these risks, and that’s keeping them from adequate screening and practicing safer sex.Joan Price, a sex educator who focuses on senior sexuality and who is the author of “Naked at Our Age: Talking Out Loud about Senior Sex,” said she was struck by the variety of reasons older daters may not practice safe sex, or even talk about it with partners.She often hears some version of, “Oh, I can’t get pregnant,” she said, or “Our age group doesn’t get S.T.I.s.” Men have told her they were reluctant to talk about barrier methods of protection because their erections were unpredictable, and using a condom made them go away.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

    More stories

    • 163 Shares199 Views

      in Elections

      Millions of Girls in Africa Will Miss HPV Shots After Merck Production Problem

      by

      The company has told countries that it can supply only 18.8 million of the 29.6 million doses it was contracted to deliver this year.Nearly 1.5 million teenage girls in some of the world’s poorest countries will miss the chance to be protected from cervical cancer because the drugmaker Merck has said it will not be able to deliver millions of promised doses of the HPV vaccine this year.Merck has notified Gavi, the international organization that helps low- and middle-income countries deliver lifesaving immunizations, and UNICEF, which procures the vaccines, that it will deliver only 18.8 million of the 29.6 million doses it was contracted to deliver in 2024, Gavi said.That means that more than 10 million girls will not receive their expected HPV shots this year — and 1.5 million of them most likely will never get them because they will be too old to qualify for the vaccine in subsequent years.Patrick Ryan, a spokesman for Merck, said the company “experienced a manufacturing disruption” that required it to hold and reinspect many doses by hand. He declined to give further details about the cause of the delay.“We are acting with urgency and rigor to deploy additional personnel and resources to resolve this matter as soon as possible,” he said.Mr. Ryan said that Merck would deliver the delayed doses in 2025. He also said the company would ship 30 million doses of the vaccine to Gavi-supported countries this year. However, about a third of these are doses that were supposed to have been sent in 2023, leaving Gavi with the 10.7 million dose shortfall.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More